FDA Inspection
New Vision Pharmaceuticals LLCNew Vision Pharmaceuticals LLC – FDA Inspection, May 7, 2019
Record Details
This FDA Inspection record concerns New Vision Pharmaceuticals LLC, with an inspection on May 7, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c0dda078-d327-4814-b670-871887187ae5
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1088783
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.42(c)(1)Incoming material area
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New Vision Pharmaceuticals LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 23, 2023 | OAI | Florida District Office | New Drug Evaluation |
| October 29, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for New Vision Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.